Recent publications from members of the Division of Hematology at WashU Med, emphasize the ongoing safety challenges of anticoagulant therapies in high-risk patient populations. “The first month after direct oral anticoagulants: a window of vulnerability” (published in Research and Practice in Thrombosis and Haemostasis), is commentary from Amber Afzal, MD, MSCI on direct oral anticoagulants (DOACs). “Anticoagulant […]
WashU Hematology Researchers Publish Findings on Anticoagulant Safety Gaps and Bleeding Risks
